UBS Reaffirms Their Buy Rating on British American Tobacco (BATS)

In a report released yesterday, Faham Baig from UBS reiterated a Buy rating on British American Tobacco, with a price target of p5,200.00.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Baig is a 2-star analyst with an average return of 1.6% and a 58.11% success rate. Baig covers the Consumer Defensive sector, focusing on stocks such as Altria Group, Philip Morris, and British American Tobacco.

In addition to UBS, British American Tobacco also received a Buy from Barclays’s Pallav Mittal in a report issued on February 23. However, yesterday, RBC Capital maintained a Sell rating on British American Tobacco (LSE: BATS).

Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion

Based on the recent corporate insider activity of 100 insiders, corporate insider sentiment is neutral on the stock.